Efficacy and safety of a dual boosted protease inhibitor-based regimen, atazanavir and fosamprenavir/ritonavir, against HIV: experience in a pediatric population

Peer Review reports

Original Submission
21 Nov 2011	Submitted	Original manuscript
5 May 2012	Reviewed	Reviewer Report - Raffaele Badolato
14 May 2012	Reviewed	Reviewer Report - Pope Kosalaraksa
6 Jun 2012	Author responded	Author comments - Stefano Rusconi
Resubmission - Version 2
6 Jun 2012	Submitted	Manuscript version 2
12 Jul 2012	Author responded	Author comments - Stefano Rusconi
Resubmission - Version 3
12 Jul 2012	Submitted	Manuscript version 3
Publishing
23 Jul 2012	Editorially accepted
6 Aug 2012	Article published	10.1186/1471-2334-12-179

Back to article page